Fast Market Research

Recently Released Market Study: AstraZeneca PLC - Product Pipeline Review - 2012

Fast Market Research recommends "AstraZeneca PLC - Product Pipeline Review - 2012" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 02/13/2013 -- Global Market Direct's pharmaceuticals report, "AstraZeneca PLC - Product Pipeline Review - 2012" provides data on the AstraZeneca PLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, AstraZeneca PLC's corporate website, SEC filings, investor presentations and featured press releases, both from AstraZeneca PLC and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents


- AstraZeneca PLC - Brief AstraZeneca PLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AstraZeneca PLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AstraZeneca PLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AstraZeneca PLC's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate AstraZeneca PLC's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of AstraZeneca PLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AstraZeneca PLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AstraZeneca PLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AstraZeneca PLC and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- BTG plc - Product Pipeline Review - 2012
- Silence Therapeutics plc - Product Pipeline Review - 2012
- Shire Plc - Product Pipeline Review - 2012
- Elan Corporation, plc - Product Pipeline Review - 2012
- Depression - Pipeline Review, H1 2012
- AstraZeneca PLC (AZN) - Financial and Strategic SWOT Analysis Review
- Ark Therapeutics Group plc - Product Pipeline Review - 2012
- Oxford BioMedica plc - Product Pipeline Review - 2012
- GW Pharmaceuticals plc - Product Pipeline Review - 2012
- Proximagen Group plc - Product Pipeline Review - 2012